Tecarfarin
- Generic Name
- Tecarfarin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C21H14F6O5
- CAS Number
- 867257-26-9
- Unique Ingredient Identifier
- WN1479YT50
- Background
Tecarfarin has been used in trials studying the prevention of Thrombosis and Thromboembolism.
- Associated Conditions
- -
- Associated Therapies
- -
An Ascending, Multiple-Dose, Safety and Tolerability Study of Tecarfarin in Healthy Chinese Volunteers
- First Posted Date
- 2020-11-13
- Last Posted Date
- 2020-11-13
- Lead Sponsor
- Lee's Pharmaceutical Limited
- Target Recruit Count
- 40
- Registration Number
- NCT04627116
- Locations
- 🇨🇳
The Second Hospital of Anhui Medical University, Hefei, China
Tecarfarin Anti-Coagulation Trial (TACT)
- First Posted Date
- 2015-08-13
- Last Posted Date
- 2018-01-25
- Lead Sponsor
- Espero Biopharma
- Target Recruit Count
- 1000
- Registration Number
- NCT02522221
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath